Study on Serum Zinc and Selenium Levels in Epileptic Patients

Arak University of Medical Sciences40 enrolled

Overview

This study was carried out with the purpose of evaluating zinc and selenium levels in serum of epileptic patients and compare with normal individuals.

Forty patients aged 18 to 50 years visiting Vali-Asr hospital in Arak, I.R. Iran, who were diagnosed with generalized form of epilepsy by a neurologist for the first time were recruited as cases. The control group (n=40) was selected from healthy individuals, in whom no disease was diagnosed until this study, and were matched to the case group by age, sex, and economical status.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Generalized Epileptic

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: New generalized and single epileptic cases patients who accept and sign the approval form of ethical committee non smoker, no trauma, no use of selenium supplement, no use of zinc supplement, no use of vitamin A supplement, no use of vitamin D supplement, no Weight loss, no Diarrhea, no addiction, no alcohol consumption, no use of certain medications, Exclusion Criteria: presence of above criteria as well as, generalized and single epileptic cases under treatment

Locations (1)

Vali-Asr Hospital

Arak, Markazi Province, Iran

Outcomes

Primary Outcomes

Study on Serum Zinc and Selenium Levels in Epileptic Patients

decrement in serum zinc and selenium level

Time frame: 5 months

Secondary Outcomes

Comparison between the selenium levels by gender in two groups

Time frame: 5 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.